Economic returns on NIHR Health Technology Assessment

PRISM researchers based at RAND Europe have analysed the economic impact of the NIHR's Health Technology Assessment (HTA) programme, which funds research on the effectiveness, costs and impacts of healthcare technologies in the NHS.

The study looks at a sample of 10 HTA-funded projects which had showed that a new treatment, if introduced in the NHS, could offer benefits either through cost savings or improved health outcomes. It also looks at the extent to which the 10 projects impacted policy and practice.

The UK National Institute for Health Research (NIHR)‘s Health Technology Assessment (HTA) programme, established in 1993, is the largest research programme dedicated to the NHS. The underlying principle of the HTA programme is that should not only use the most rigorous techniques, but should also be needs-led, with a clear benefit to patients and practitioners.

Related Content

Publications

People

Steven Wooding

Steven Wooding

Steven Wooding, PhD is a Senior Research Leader in the Innovation, Health and Science programme at RAND Europe and has worked extensively on the 'science of science' and the evaluation of biomedical research.

More...
Susan Guthrie

Susan Guthrie

Susan Guthrie is a Senior Analyst at RAND Europe. Her primary research interests are in the area of science and innovation policy, with a particular interest in evaluation, performance monitoring and research strategy.

More...